OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19
Irina Kusmartseva, Wenting Wu, Farooq Syed, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 1041-1051.e6
Open Access | Times Cited: 160

Showing 1-25 of 160 citing articles:

SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
Janis A. Müller, Rüdiger Groß, Carina Conzelmann, et al.
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 149-165
Open Access | Times Cited: 507

Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
Laura Montefusco, Moufida Ben Nasr, Francesca D’Addio, et al.
Nature Metabolism (2021) Vol. 3, Iss. 6, pp. 774-785
Open Access | Times Cited: 356

SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment
Chien-Ting Wu, Peter V. Lidsky, Yinghong Xiao, et al.
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1565-1576.e5
Open Access | Times Cited: 300

COVID-19, Hyperglycemia, and New-Onset Diabetes
Kamlesh Khunti, Stefano Del Prato, Chantal Mathieu, et al.
Diabetes Care (2021) Vol. 44, Iss. 12, pp. 2645-2655
Open Access | Times Cited: 278

Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
Ioannis P. Trougakos, Κimon Stamatelopoulos, Evangelos Terpos, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 240

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
Daniel J. Drucker
Cell Metabolism (2021) Vol. 33, Iss. 3, pp. 479-498
Open Access | Times Cited: 239

Post-acute COVID-19 syndrome
David Montani, Laurent Savale, Nicolas Noël, et al.
European Respiratory Review (2022) Vol. 31, Iss. 163, pp. 210185-210185
Open Access | Times Cited: 213

COVID-19 and metabolic disease: mechanisms and clinical management
Charlotte Steenblock, Peter E. H. Schwarz, Barbara Ludwig, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 11, pp. 786-798
Open Access | Times Cited: 206

COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
Cyril P. Landstra, Eelco J.P. de Koning
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 174

SARS-CoV-2 infection induces beta cell transdifferentiation
Xuming Tang, Skyler Uhl, Tuo Zhang, et al.
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1577-1591.e7
Open Access | Times Cited: 168

SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells
Katie C. Coate, Jeeyeon Cha, Shristi Shrestha, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 1028-1040.e4
Open Access | Times Cited: 167

Viral infiltration of pancreatic islets in patients with COVID-19
Charlotte Steenblock, Stefanie Richter, Ilona Berger, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 166

Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, et al.
Cell Metabolism (2021) Vol. 33, Iss. 11, pp. 2174-2188.e5
Open Access | Times Cited: 161

Can COVID-19 cause diabetes?
Domenico Accili
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 123-125
Open Access | Times Cited: 127

Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis
Ting Zhang, Qimin Mei, Zhaocai Zhang, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 113

Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry
Clemens Kamrath, Joachim Rosenbauer, Alexander J. Eckert, et al.
Diabetes Care (2022) Vol. 45, Iss. 8, pp. 1762-1771
Open Access | Times Cited: 108

Impact of COVID-19 on the Endocrine System: A Mini-review
Sophie Clarke, Ali Abbara, Waljit S. Dhillo
Endocrinology (2021) Vol. 163, Iss. 1
Open Access | Times Cited: 100

Advances in Pancreatic Islet Transplantation Sites for the Treatment of Diabetes
Fritz Cayabyab, Lina R. Nih, Eiji Yoshihara
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 84

Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients
Dickson W.L. Wong, Barbara M. Klinkhammer, Sonja Djudjaj, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1900-1900
Open Access | Times Cited: 65

Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study
Shivani Misra, Emma Barron, Eszter P. Vamos, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 10, pp. 671-680
Open Access | Times Cited: 65

Diabetes and COVID-19; A Bidirectional Interplay
Paraskevi Kazakou, Vaia Lambadiari, Ignatios Ikonomidis, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 64

SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes
Mirza Muhammad Fahd Qadir, Manika Bhondeley, Wandy L. Beatty, et al.
JCI Insight (2021) Vol. 6, Iss. 16
Open Access | Times Cited: 56

Limited extent and consequences of pancreatic SARS-CoV-2 infection
Verena van der Heide, Sonia Jangra, Phillip Cohen, et al.
Cell Reports (2022) Vol. 38, Iss. 11, pp. 110508-110508
Open Access | Times Cited: 48

Page 1 - Next Page

Scroll to top